Shandong Xinhua Pharmaceutical Co Ltd (000756) — Working Capital to Net Assets Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Working Capital to Net Assets ratio of 15.7% as of June 2025. Working capital of CN¥839.89 Million (current assets of CN¥3.99 Billion minus current liabilities of CN¥3.15 Billion) is measured against net assets of CN¥5.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shandong Xinhua Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shandong Xinhua Pharmaceutical Co Ltd Working Capital to Net Assets (2015–2024)
This chart shows how Shandong Xinhua Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 15.7%, reflecting working capital of CN¥839.89 Million against net assets of CN¥5.36 Billion CNY. See 000756 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Shandong Xinhua Pharmaceutical Co Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 17.8% | CN¥931.23 Million | CN¥5.22 Billion | CN¥3.73 Billion | CN¥2.80 Billion | ▲ +0.5 pp |
| 2023 | 17.3% | CN¥828.33 Million | CN¥4.78 Billion | CN¥3.31 Billion | CN¥2.49 Billion | ▲ +10.5 pp |
| 2022 | 6.9% | CN¥298.47 Million | CN¥4.35 Billion | CN¥3.46 Billion | CN¥3.16 Billion | ▼ 0.0 pp |
| 2021 | 6.9% | CN¥252.08 Million | CN¥3.65 Billion | CN¥2.75 Billion | CN¥2.50 Billion | ▼ -2.1 pp |
| 2020 | 9.0% | CN¥305.83 Million | CN¥3.39 Billion | CN¥2.69 Billion | CN¥2.38 Billion | ▲ +10.9 pp |
| 2019 | -1.8% | CN¥-57.13 Million | CN¥3.11 Billion | CN¥2.43 Billion | CN¥2.49 Billion | ▼ -2.6 pp |
| 2018 | 0.7% | CN¥20.45 Million | CN¥2.80 Billion | CN¥2.38 Billion | CN¥2.36 Billion | ▼ -19.4 pp |
| 2017 | 20.1% | CN¥519.15 Million | CN¥2.58 Billion | CN¥2.01 Billion | CN¥1.49 Billion | ▲ +47.1 pp |
| 2016 | -26.9% | CN¥-559.92 Million | CN¥2.08 Billion | CN¥1.71 Billion | CN¥2.27 Billion | ▼ -11.8 pp |
| 2015 | -15.1% | CN¥-299.44 Million | CN¥1.98 Billion | CN¥1.65 Billion | CN¥1.95 Billion | — |